Akèy › Kansè pwostat rezistan a kastasyon › Pennsylvania
Etid klinik pou Kansè pwostat rezistan a kastasyon nan Pennsylvania
5 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Lehigh Valley Hospital, Allentown
- MidLantic Urology, Bala-Cynwyd
- Penn State Milton S. Hershey Medical Center, Hershey
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- MidLantic Urology, Bala-Cynwyd
- Keystone Urology Specialists, Lancaster
- Penn Medicine Abramson Cancer Center, Philadelphia
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- UPMC Hillman Cancer Center ( Site 0014), Pittsburgh
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06863272A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Penn State Milton S. Hershey Medical Center, Hershey
- Thomas Jefferson University Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.